(via TheNewswire)
The Company also announces that it is continuing its efforts to complete the concurrent financing in connection with the Transaction. Further details of the Transaction, the securities exchange agreement, as amended, and the concurrent financing are set out in the Company’s filing statement dated
For further information regarding the Company, contact:
doron@alabs.co
972 545-224-017
For further information regarding Orcanos, please contact:
zoharp@orcanos.com
972-525-582-578
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE
Caution Regarding Forward-Looking Information
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Forward looking statements in this news release include, but are not limited to: the closing of the Transaction, concurrent financing and related transactions, and the extension for the Transaction deadline will be met. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statement will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Copyright (c) 2022 TheNewswire - All rights reserved.
Copyright (c) 2022 TheNewswire - All rights reserved., source